Cadila Launches Tarzed For Early-stage Breast Cancer

24th Jan, 2022 | News

Cadila Pharmaceuticals has launched trastuzumab under the brand name Tarzed. It is a humanized monoclonal antibody and is recommended for HER2-positive early-stage breast cancer and metastatic breast cancer.

Navjeevan Express

India News Republic

Health Vision

Free Express

ET Healthworld

ET Express Pharma

Bio Voice

Prabhat

Suger Mint

Array
(
    [HandLtestDomainNameServer] => HandLtestDomainValueServer
    [handl_ip] => 3.136.25.185,3.136.25.185
    [handl_url_base] => https://trustinform.com/overcome-your-emotional-eating-with-therapy/
    [organic_source] => https://trustinform.com/overcome-your-emotional-eating-with-therapy
    [_vsid] => e355234a-7c27-4290-b7cb-be2aff80128c
    [handl_original_ref] => https://trustinform.com/overcome-your-emotional-eating-with-therapy
    [handl_landing_page] => https://trustinform.com/overcome-your-emotional-eating-with-therapy
    [handl_ref] => https://trustinform.com/overcome-your-emotional-eating-with-therapy
    [handl_url] => https://trustinform.com/overcome-your-emotional-eating-with-therapy/
    [organic_source_str] => Internal
    [user_agent] => Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)
)